A rare disease survivor, Megan Crowley, and her father John Crowley, were introduced to U.S. Congress on Feb. 28, 2017, when former U.S. President Donald Trump gave a speech to Congress marking Rare Disease Day. Megan was born with Pompe disease due to a rare genetic disorder. Megan and her younger
The J.P. Morgan Healthcare Conference, the world’s largest healthcare conference that draws institutional investors' attention, will soon kick off in San Francisco, the U.S., from Jan. 9-12.The conference, which has been held every year since 1983, celebrates its 41st anniversary. Hosted by global i
Jung Ki-suck, head of the National Advisory Committee on Infectious Disease Crisis Response, questioned why the government should take responsibility for treating unvaccinated Covid-19 patients."Testing positive for Covid-19 after not getting a vaccine is no different from a traffic accident caused
HLB Therapeutics said on Monday that the first phase 3 clinical trial results (SEER-1) of its Neurotrophic Keratopathy (NK) treatment RGN-259 demonstrated effectiveness and safety in a recently published study in the International Journal of Molecular Sciences.The research team comprising of HLB The
Headwinds such as the waning interest in Covid-19-related stocks and a looming global economic recession sapped the market capitalization of Korean biopharmaceutical companies by 68 trillion won ($53.4 billion) in 2022, industry data showed.According to financial data of 253 biopharmaceutical stocks
“As an old saying goes, ‘A clever rabbit has three holes in ready.’ So the Ministry of Food and Drug Safety will prepare for the future as the highest agency that protects the public’s health, making policies by flexibly coping with new changes, making open communication, and strengthening expertise
“Research and development in medical and biopharmaceutical fields have been made through scientists’ trials and error in the past. Today, however, the insight of artificial intelligence takes the lead in their development through big data in every stage.”Kim Kyeong-nam, a Korea Institute for Science
Two local administrations are vying to attract Merck’s plant manufacturing raw and subsidiary materials for biopharmaceutical products.According to industry sources on Monday, the German-based multinational pharmaceutical company plans to build additional manufacturing facilities of intermediate mat
SK Chemicals said it launched Italfarmaco's Teglutik Oral Suspension, a Lou Gehrig's disease treatment.Lou Gehrig's disease can lead to paralysis of the limbs and respiratory muscles due to the gradual destruction of motor nerve cells.As of 2022, there were 4,709 patients with Lou Gehrig's disease i
Hyundai Pharmaceutical said on Monday that it will launch a 20mg dose of Dimantine (ingredient: memantine hydrochloride), an Alzheimer's disease treatment that improved patient convenience, in the domestic market. Dimantine is a non-competitive antagonist of N-methyl-D-aspartate (NMDA) receptor-base
Dx & Vx said Friday that it has signed a 3 billion won ($2.38 million) contract with COREE to provide precision medical genome analysis service.The research project began this year and aimed to turn 10 thousand or more immunocyte profiling results into big data for three years.COREE, which focuses o
The Health Insurance Review and Assessment Service (HIRA) has decided to leave Australia as a reference country when it sets drug prices next year. HIRA disclosed this through its "detailed evaluation criteria for drugs subject to negotiation," released Wednesday.The evaluation criteria include the
GI Innovation said Thursday that it has won approval in the preliminary screening to be listed on the Kosdaq market from the Korea Exchange (KRX). The approval came eight months after the company applied for a preliminary review in April.GI Innovation plans to make various preparations, submit a sec
Alteogen said Friday that it has signed a technology export contract with Sandoz AG regarding one item applied by human recombinant hyaluronidase, ALT-B4, made from the SC (subcutaneous) formulation-changing platform, Hybrozyme.The contract preferentially provides Sandoz with the exclusive right of
To minimize the impact of China’s worsening Covid-19 situation, the Korean government decided to strengthen quarantine measures.Seoul will limit the number of short-term visa issuance and additional flights from China to Korea and make Covid-19 tests before and after entry into Korea mandatory from
Aprogen, which raised investors’ expectations by announcing acquiring a drug manufacturing facility in the U. S., has reversed the announcement and abandoned its acquisition.“In these times of global business slump, we thought the investment risk would increase sharply and decided not to push for th
“Essential healthcare” has emerged as the most prominent topic of Korea’s medical community in 2022, replacing Covid-19. However, that was not the only controversy this year. As the political power changed through the presidential election in March, significant changes were also predicted in health
In 2022, the Korean healthcare industry seemed out of the Covid-19 shock. However, the industry had a rough year amid the economic downturn, jittery investor sentiment, and higher costs of imported raw materials. Nevertheless, the local healthcare industry showed a glimpse of future growth as conglo
Korean endocrinology physicians agreed that oral insulin preparations under development by Oramed Pharmaceutical would not be able to replace existing insulin injections.They expressed the view during a press briefing where Oramed and Medicox, a local pharmaceutical company, announced the clinical s
Humasis, a Korean in-vitro diagnostic medical device company, said Thursday that Celltrion has terminated a contract to supply Humasis' at-home Covid-19 antigen diagnosis kit.The two companies initially signed the contract worth $114.78 million (133.6 billion won) on Jan. 22.However, Humasis explain